MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clnu.2021.03.001

Медицинская библиотека · Clinical nutrition (Edinburgh, Scotland) · 2021

Vitamin D deficiency in critically ill COVID-19 ARDS patients.

Notz Quirin, Herrmann Johannes, Schlesinger Tobias, Kranke Peter, Sitter Magdalena, Helmer Philipp, Stumpner Jan, Roeder Daniel, Amrein Karin, Stoppe Christian, Lotz Christopher, Meybohm Patrick

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND & AIMS: Vitamin D's pleiotropic effects include immune modulation, and its supplementation has been shown to prevent respiratory tract infections. The effectivity of vitamin D as a therapeutic intervention in critical illness remains less defined. The current study analyzed clinical and immunologic effects of vitamin D levels in patients suffering from coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS).

METHODS

This was a single-center retrospective study in patients receiving intensive care with a confirmed SARS-CoV-2 infection and COVID-19 ARDS. 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum levels, pro- and anti-inflammatory cytokines and immune cell subsets were measured on admission as well as after 10-15 days. Clinical parameters were extracted from the patient data management system. Standard operating procedures included the daily administration of vitamin D3 via enteral feeding.

RESULTS

A total of 39 patients with COVID-19 ARDS were eligible, of which 26 were included in this study as data on vitamin D status was available. 96% suffered from severe COVID-19 ARDS. All patients without prior vitamin D supplementation (n = 22) had deficient serum levels of 25-hydroxyvitamin D. Vitamin D supplementation resulted in higher serum levels of 25-hydroxyvitamin D but not did not increase 1,25-dihydroxyvitamin D levels after 10-15 days. Clinical parameters did not differ between patients with sufficient or deficient levels of 25-hydroxyvitamin D. Only circulating plasmablasts were higher in patients with 25-hydroxyvitamin D levels ≥30 ng/ml (p = 0.029). Patients with 1,25-dihydroxyvitamin D levels below 20 pg/ml required longer mechanical ventilation (p = 0.045) and had a worse acute physiology and chronic health evaluation (APACHE) II score (p = 0.048).

CONCLUSION

The vast majority of COVID-19 ARDS patients had vitamin D deficiency. 25-hydroxyvitamin D status was not related to changes in clinical course, whereas low levels of 1,25-dihydroxyvitamin D were associated with prolonged mechanical ventilation and a worse APACHE II score.

Для цитирования: Notz Quirin, Herrmann Johannes, Schlesinger Tobias, Kranke Peter, Sitter Magdalena, Helmer Philipp, Stumpner Jan, Roeder Daniel, Amrein Karin, Stoppe Christian, Lotz Christopher, Meybohm Patrick. Vitamin D deficiency in critically ill COVID-19 ARDS patients.. Clinical nutrition (Edinburgh, Scotland). 2021. DOI: 10.1016/j.clnu.2021.03.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.